Osteoarthritis (OA) is a common disease that endangers millions of middle‐aged and elderly
people worldwide. Researchers from different fields have made great efforts and achieved …

Drug delivery for osteoarthritis (OA) treatment is a continuous challenge because of their
poor bioavailability and rapid clearance in joints. Intra-articular (IA) drug delivery is a …

Background The purpose of this study was to perform an updated meta-analysis to compare
the outcomes of kinematic alignment (KA) and mechanical alignment (MA) in patients …

In vivo articular cartilage degeneration is an essential hallmark of osteoarthritis (OA),
involving chondrocyte senescence, extracellular matrix degradation, chondrocyte death …

Electrical stimulation (ES) induces wound healing and skin regeneration. Combining ES
with the tissue-engineering approach, which relies on biomaterials to construct a …

Carbon monoxide (CO) has great potential in the therapy of osteoarthritis (OA), but its
controllable delivery in vivo is still an intractable problem. To optimize CO gas therapy for …

Osteoarthritis (OA) is the most common cause of disability worldwide among the elderly.
Alarmingly, the incidence of OA in individuals less than 40 years of age is rising, likely due to …

Objective Our previous studies revealed that normal synovial exosomes promoted
chondrogenesis, and microRNA (miR)-19b-3p independently related to osteoarthritis (OA) …

Viscosupplementation by hyaluronic acid (HA) is recommended for non-surgical
management of knee osteoarthritis (OA). This study investigated the efficacy and safety of a …

Objective To identify and synthesize patient-related barriers to and enablers of the
implementation of high-value physiotherapy (HVP) for chronic pain. Furthermore, to review …